Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- REVBW
- Price
- 0.01
- Stock movement up
- +- (%)
- Company name
- Revelation Biosciences Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- -
- Ent value
- -2.47M
- Price/Sales
- -
- Price/Book
- -
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -53.93%
- 3 year return
- -58.32%
- 5 year return
- -
- 10 year return
- -
Last updated: 2025-04-12
iO Charts is a Seeking Alpha partner
DIVIDENDS
REVBW does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | - |
| EV to Sales | -65.86 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | - |
| EPS (TTM) | -5.79 |
| FCF per share (TTM) | -8.06 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 37.57K |
| Gross profit (TTM) | 17.83K |
| Operating income (TTM) | -8.55M |
| Net income (TTM) | -15.52M |
| EPS (TTM) | -5.79 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | 47.45% |
| Operating margin (TTM) | -22747.42% |
| Profit margin (TTM) | -41293.77% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 6.54M |
| Net receivables | 0.00 |
| Total current assets | 6.66M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 168.82K |
| Total assets | 6.74M |
| Accounts payable | 3.13M |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 4.07M |
| Total liabilities | 4.07M |
| Shareholder's equity | 2.67M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -21.54M |
| Capital expenditures (TTM) | 56.03K |
| Free cash flow (TTM) | -21.60M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -580.33% |
| Return on Assets | -230.20% |
| Return on Invested Capital | -580.33% |
| Cash Return on Invested Capital | -807.73% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 0.01 |
| Daily high | 0.01 |
| Daily low | 0.01 |
| Daily Volume | 0K |
| All-time high | 0.65 |
| 1y analyst estimate | - |
| Beta | 0.15 |
| EPS (TTM) | -5.79 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| REVBW | S&P500 | |
| Current price drop from All-time high | -98.02% | -12.89% |
| Highest price drop | -100.00% | -56.47% |
| Date of highest drop | 24 Nov 2023 | 9 Mar 2009 |
| Avg drop from high | -93.50% | -11.07% |
| Avg time to new high | 391 days | 12 days |
| Max time to new high | 779 days | 1805 days |
COMPANY DETAILS
Marketcap
-
Marketcap category
Small-cap
Description
Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. It engages in developing therapeutic product candidates, including GEM-SSI, a potential therapy for the prevention and treatment of surgical sit infection; GEM-AKI, a potential therapy for the prevention and treatment of acute kidney injury; and GEM-CKD, a potential therapy for the prevention and treatment of chronic kidney disease. The company was founded in 2020 and is based in San Diego, California.
Employees
9
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner